| --- | --- | |-------|-----------------------------------------------------------------------------| | | | | | | | | | | | | | | Immunic Therapeutics Developing Selective Oral Drugs in Immunology | | | NASDAQ: IMUX 39th Annual Canaccord Genuity Growth Conference August 8, 2019 | Cautionary Note Regarding Forward-Looking Statements • Certain statements contained in this presentation regarding matters that are not historical facts are forward-looking statements within the meaning of Section 21E of the Securi ...